• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎的成本。

The cost of atopic eczema.

作者信息

Herd R M, Tidman M J, Prescott R J, Hunter J A

机构信息

Department of Dermatology, University of Edinburgh, U.K.

出版信息

Br J Dermatol. 1996 Jul;135(1):20-3.

PMID:8776353
Abstract

Atopic eczema affects 2.3% of the U.K. population. We have carried out a community study in a semi-rural area to assess its economic impact. One hundred and fifty-five patients with atopic eczema were identified and expenditure was assessed over a 2-month period. The mean personal cost to the patient was pounds 25.90, while the mean cost to the health service was pounds 16.20. There were 58 lost working days and 17 lost school days. A cohort of 10 severely affected patients attending the Royal Infirmary of Edinburgh were studied; each patient spent, on average, pounds 325 in 2 months, and lead to a mean health service expenditure per patient of pounds 415, in 2 months. If these results were extrapolated to the U.K. population, the annual personal cost to patients with atopic eczema would be pounds 297m, the cost to the health service would be pounds 125m, and the annual cost to society of lost working days would be pounds 43m, making the total expenditure on atopic eczema pounds 465m.

摘要

特应性湿疹影响着2.3%的英国人口。我们在一个半乡村地区开展了一项社区研究,以评估其经济影响。确定了155名特应性湿疹患者,并对其两个月期间的支出进行了评估。患者的平均个人成本为25.90英镑,而医疗服务的平均成本为16.20英镑。有58个工作日和17个上学日的损失。对在爱丁堡皇家医院就诊的10名重症患者进行了队列研究;每位患者在两个月内平均花费325英镑,导致医疗服务平均每位患者在两个月内支出415英镑。如果将这些结果推算至英国人口,特应性湿疹患者的年度个人成本将为2.97亿英镑,医疗服务成本将为1.25亿英镑,因工作日损失给社会带来的年度成本将为4300万英镑,使得特应性湿疹的总支出达到4.65亿英镑。

相似文献

1
The cost of atopic eczema.特应性皮炎的成本。
Br J Dermatol. 1996 Jul;135(1):20-3.
2
A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.吡美莫司与外用皮质类固醇和润肤剂治疗轻度和中度特应性皮炎的成本-效用分析
Br J Dermatol. 2006 Jun;154(6):1137-46. doi: 10.1111/j.1365-2133.2006.07184.x.
3
The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective.特应性皮炎的直接和间接成本负担:雇主-支付方视角
Manag Care Interface. 2007 Oct;20(10):26-32.
4
Burden of Atopic dermatitis in Canada.加拿大特应性皮炎的负担。
Int J Dermatol. 2006 Jan;45(1):31-6. doi: 10.1111/j.1365-4632.2004.02345.x.
5
Prevalence of atopic eczema in the community: the Lothian Atopic Dermatitis study.社区中特应性皮炎的患病率:洛锡安特应性皮炎研究
Br J Dermatol. 1996 Jul;135(1):18-9.
6
Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs.护士从业者与皮肤科医生治疗儿童湿疹的成本和成本效益分析:一项随机对照试验的结果和国际成本回顾。
Br J Dermatol. 2011 Sep;165(3):600-11. doi: 10.1111/j.1365-2133.2011.10470.x.
7
The OMENS trial: opportunistic evaluation of musculo-skeletal physician care among orthopaedic outpatients unlikely to require surgery.OMENS试验:对不太可能需要手术的骨科门诊患者进行肌肉骨骼科医生护理的机会性评估。
Health Bull (Edinb). 2001 May;59(3):198-210.
8
Atopic dermatitis in Italian children: evaluation of its economic impact.意大利儿童的特应性皮炎:对其经济影响的评估。
J Pediatr Health Care. 2006 Sep-Oct;20(5):311-5. doi: 10.1016/j.pedhc.2006.04.009.
9
Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.丘脑底核深部脑刺激治疗帕金森病患者的医疗利用情况和健康状况评估
J Neurol. 2002 Jun;249(6):759-66. doi: 10.1007/s00415-002-0711-7.
10
Assessment of outcomes and parental effect on Quality-of-Life endpoints in the management of atopic dermatitis.特应性皮炎管理中结局及父母因素对生活质量终点指标的评估。
Manag Care Interface. 2007 Feb;20(2):18-23.

引用本文的文献

1
Introduction.引言。
Adv Exp Med Biol. 2024;1447:1-10. doi: 10.1007/978-3-031-54513-9_1.
2
Electromagnetic Sensing Techniques for Monitoring Atopic Dermatitis-Current Practices and Possible Advancements: A Review.电磁感应技术在特应性皮炎监测中的应用:现状与可能的进展:综述。
Sensors (Basel). 2023 Apr 12;23(8):3935. doi: 10.3390/s23083935.
3
Understanding economic evidence for the prevention and treatment of atopic eczema.理解特应性皮炎预防和治疗的经济学证据。
Br J Dermatol. 2019 Oct;181(4):707-716. doi: 10.1111/bjd.17696. Epub 2019 Apr 11.
4
Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink.英国初级医疗中为儿童和成人开具润肤剂治疗特应性皮炎的成本与效果:基于临床实践研究数据链的大型回顾性分析
BMC Dermatol. 2018 Oct 29;18(1):9. doi: 10.1186/s12895-018-0076-y.
5
House Dust Mite Prevalence in the House of Patients with Atopic Dermatitis in Mashhad, Iran.伊朗马什哈德特应性皮炎患者家中屋尘螨的患病率
J Arthropod Borne Dis. 2017 May 27;11(2):309-314. eCollection 2017 Jun.
6
The Use of Decision-Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal.决策分析模型在特应性皮炎中的应用:系统评价和批判性评估。
Pharmacoeconomics. 2018 Jan;36(1):51-66. doi: 10.1007/s40273-017-0564-7.
7
Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists.英国成人中重度特应性皮炎的治疗:皮肤科医生全国调查结果
Br J Dermatol. 2017 Jun;176(6):1617-1623. doi: 10.1111/bjd.15235. Epub 2017 Apr 16.
8
Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review.特应性皮炎预防与治疗的经济学证据:一项系统评价方案
Syst Rev. 2016 May 27;5:90. doi: 10.1186/s13643-016-0262-0.
9
Bath additives for the treatment of childhood eczema (BATHE): protocol for multicentre parallel group randomised trial.用于治疗儿童湿疹的沐浴添加剂(BATHE):多中心平行组随机试验方案
BMJ Open. 2015 Nov 1;5(10):e009575. doi: 10.1136/bmjopen-2015-009575.
10
Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics.特应性皮炎中的免疫途径,以及通过广泛和靶向治疗确定生物标志物的定义。
J Clin Med. 2015 Apr 29;4(5):858-73. doi: 10.3390/jcm4050858.